Mellitus

Medical Devices, 50 Milk St Fl 16, Boston, Massachusetts, 02109, United States, 1-10 Employees

mellitusllc.com

  • LinkedIn

phone no Phone Number: 61********

Who is MELLITUS

Mellitus is dedicated to advancing diabetes detection and monitoring through products based on GCD59, a biomarker of glycemic load that is unique because of its direct relationship to the...

Read More

map

industries-icon Industry: Medical Devices

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from MELLITUS

Mellitus Org Chart and Mapping

Employees

Marianne Ghizzoni

Director, Business Operations and Brand Management

Jing Shi

Principal Scientist

Shailendra Kumar

Chief Scientific Officer

Michael Chorev

Founder and Board Member

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Mellitus

Answer: Mellitus's headquarters are located at 50 Milk St Fl 16, Boston, Massachusetts, 02109, United States

Answer: Mellitus's phone number is 61********

Answer: Mellitus's official website is https://mellitusllc.com

Answer: Mellitus's revenue is Under $1 Million

Answer: Mellitus's SIC: 2836

Answer: Mellitus's NAICS: 541714

Answer: Mellitus has 1-10 employees

Answer: Mellitus is in Medical Devices

Answer: Mellitus contact info: Phone number: 61******** Website: https://mellitusllc.com

Answer: Mellitus is dedicated to advancing diabetes detection and monitoring through products based on GCD59, a biomarker of glycemic load that is unique because of its direct relationship to the complications of diabetes. Our premier application is a patient-friendly test for gestational diabetes, enabling more timely intervention to improve the health of both mother and child. We plan to commercialize our products through strategic partners as we expand indications to benefit all individuals with diabetes. GDM also known as diabetes in pregnancy, is a major cause of adverse pregnancy outcomes for both babies and mothers. Approximately four million pregnant women are screened for GDM each year in the United States alone. Because treatment of GDM mitigates the risk of complications, practice guidelines from professional organizations such as the American College of Obstetrics and Gynecology and the American Diabetes Association recommend screening of all non-diabetic pregnant women for GDM. Current standard-of-care tests for the screening and diagnosis of GDM are time consuming, uncomfortable for the patients and are reported to have poor reproducibility, highlighting the need for an accurate, simpler and more patient-friendly test for GDM.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access